Cite
HARVARD Citation
Ward, A. et al. (2016). Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers. Breast cancer research. 18 (1), pp. 1-21. [Online].